GlassScriptPhysician profile
Solomon Hayon
NPI 1023544046
$4,369.91
in general payments reported to CMS, 2019-2025
8 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2023: $3,523 · 2024: $555 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,150 · Food and Beverage: $1,801 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,149.61 |
| Food and Beverage | $1,800.64 |
| Education | $280.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,157.72 | 2023-2025 | Ams 700 Cxr Rte Kit, Ams 700, Advance Xp |
| Coloplast Corp | $1,718.82 | 2023 | Titan |
| Endo Pharmaceuticals INC. | $224.60 | 2021-2024 | Xiaflex |
| Tempus Ai, INC | $95.48 | 2024 | Xt Cdx |
| Antares Pharma, INC. | $71.50 | 2023-2025 | Xyosted, Tlando |
| Olympus America INC. | $57.64 | 2021-2025 | Itind System |
| Verity Pharmaceuticals INC. | $24.86 | 2025 | Trelstar |
| Teleflex LLC | $19.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solomon Hayon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.